SCM
PCVX icon

Soleus Capital Management’s Vaxcyte PCVX Stock Holding History

Soleus Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-385,472
Closed -$22.4M – 107
2026
Q1 		$22.4M Sell
385,472
-223,486
-37% -$12.1M 0.91% 31
2025
Q4 		$28.1M Buy
+608,958
New +$27.2M 1.04% 26
2025
Q1 		– Sell
-99,050
Closed -$8.11M – 87
2024
Q4 		$8.11M Buy
99,050
+72,000
+266% +$7.15M 0.51% 46
2024
Q3 		$3.09M Sell
27,050
-158,200
-85% -$14.3M 0.24% 72
2024
Q2 		$14M Sell
185,250
-22,500
-11% -$1.53M 1.23% 30
2024
Q1 		$14.2M Sell
207,750
-207,700
-50% -$14.4M 1.05% 29
2023
Q4 		$26.1M Sell
415,450
-84,200
-17% -$4.37M 2.89% 13
2023
Q3 		$25.5M Sell
499,650
-71,600
-13% -$3.53M 2.35% 10
2023
Q2 		$28.5M Buy
571,250
+191,000
+50% +$9.05M 3.17% 9
2023
Q1 		$14.3M Sell
380,250
-7,700
-2% -$327K 1.48% 20
2022
Q4 		$18.6M Buy
387,950
+52,300
+16% +$2.05M 2.67% 12
2022
Q3 		$8.06M Sell
335,650
-35,000
-9% -$887K 1.09% 28
2022
Q2 		$8.06M Buy
370,650
+42,300
+13% +$979K 1.26% 28
2022
Q1 		$7.93M Buy
328,350
+33,600
+11% +$734K 1.02% 33
2021
Q4 		$7.01M Sell
294,750
-60,900
-17% -$1.42M 0.7% 31
2021
Q3 		$9.02M Sell
355,650
-20,000
-5% -$485K 1.41% 23
2021
Q2 		$8.46M Buy
375,650
+82,000
+28% +$1.68M 1.3% 22
2021
Q1 		$5.8M Buy
+293,650
New +$7.39M 1.05% 18

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Soleus Capital Management's PCVX Position: Q2 2026 in Review

Soleus Capital Management sold out of Vaxcyte (PCVX) in Q2 2026, closing a stake of 385,472 shares — an estimated $22.4M sold.

Soleus Capital Management first reported a position in PCVX in Q1 2021 and held it in 18 quarters. The position peaked at $28.5M in Q2 2023. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Soleus Capital Management reported no remaining Vaxcyte position as of Q2 2026 after selling out during the quarter.
  • Soleus Capital Management sold 385,472 Vaxcyte shares in Q2 2026, an estimated $22.4M.
  • Soleus Capital Management first reported a position in Vaxcyte in Q1 2021 and held it in 18 quarters.
  • Soleus Capital Management's Vaxcyte position peaked at $28.5M in Q2 2023.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.